Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 49 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 39 | 1,859+1.8%/yr | +1.8%/yr | 4.41.4× | 0% | 2,180 in 2030+2.7%/yr |
| Decompression & minimally invasive spine | 29 | 1,488−6.6%/yr | −6.6%/yr | 3.51.1× | 5% | 1,490 in 2030+0.1%/yr |
| Cervical fusion & disc arthroplasty | 21 | 996−3.3%/yr | −3.3%/yr | 2.31.4× | 2% | 1,040 in 2030+0.8%/yr |
| Kyphoplasty & vertebroplasty | 3 | 600−4.7%/yr | −4.7%/yr | 1.40.8× | 24% | 620 in 2030+0.4%/yr |
| SI joint fusion | 1 | 124+13%/yr | +13%/yr | 0.30.8× | 0% | 350 in 2030+19%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 246 | 53,907−1.2%/yr | −1.2%/yr | 125.31.1× | 42% | 63,600 in 2030+2.8%/yr |
| Skin substitutes & wound grafts | 33 | 6,694+10%/yr | +10%/yr | 9.40.8× | 82% | 12,700 in 2030+11%/yr |
| Bone graft & orthobiologics | 8 | 369−1.6%/yr | −1.6%/yr | 0.91.3× | 1% | 360 in 2030−0.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 95 | 8,745+0.5%/yr | +0.5%/yr | 20.31.5× | 63% | 10,700 in 2030+3.4%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 4 | 441+6.5%/yr | +6.5%/yr | 1.00.7× | 46% | 410 in 2030−1.4%/yr |
| Spinal cord & DRG stimulation | 10 | 385−5.1%/yr | −5.1%/yr | 0.90.9× | 52% | 420 in 2030+1.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 12 | 2,691−14%/yr | −14%/yr | 6.31.0× | 32% | 2,760 in 2030+0.4%/yr |
| Dialysis access | 35 | 2,265−18%/yr | −18%/yr | 5.81.1× | 26% | 2,030 in 2030−1.8%/yr |
| Superficial venous ablation | 25 | 1,654−4.9%/yr | −4.9%/yr | 3.80.6× | 99% | 1,580 in 2030−0.8%/yr |
| Carotid revascularization | 17 | 665−8.6%/yr | −8.6%/yr | 1.61.2× | 0% | 580 in 2030−2.4%/yr |
| Thrombectomy, IVC filters & venous stents | 4 | 589−13%/yr | −13%/yr | 1.50.8× | 0% | 560 in 2030−0.8%/yr |
| Aortic endografts (EVAR/TEVAR) | 0 | 167−8.5%/yr | −8.5%/yr | 0.40.9× | 0% | 140 in 2030−2.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 21 | 2,378−5.5%/yr | −5.5%/yr | 6.21.0× | 3% | 2,210 in 2030−1.2%/yr |
| Cholecystectomy & appendectomy | 56 | 2,158−8.2%/yr | −8.2%/yr | 5.41.2× | 3% | 2,120 in 2030−0.3%/yr |
| Colorectal resection | 3 | 766−7.5%/yr | −7.5%/yr | 1.91.1× | 0% | 690 in 2030−1.6%/yr |
| Antireflux & hiatal hernia surgery | 4 | 371−4.8%/yr | −4.8%/yr | 0.91.2× | 0% | 300 in 2030−3.6%/yr |
| Breast reconstruction | 7 | 352+3.9%/yr | +3.9%/yr | 0.91.8× | 0% | 790 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 45 | 2,342−1%/yr | −1%/yr | 5.81.1× | 0% | 2,550 in 2030+1.4%/yr |
| BPH procedures | 22 | 1,850−5.9%/yr | −5.9%/yr | 4.50.9× | 30% | 1,540 in 2030−3.1%/yr |
| Incontinence, prolapse & sacral neuromodulation | 10 | 866−4%/yr | −4%/yr | 2.10.8× | 3% | 710 in 2030−3.3%/yr |
| Hysterectomy, hysteroscopy & ablation | 4 | 800−6.4%/yr | −6.4%/yr | 2.20.8× | 14% | 710 in 2030−2%/yr |
| Prostatectomy & nephrectomy | 4 | 514−3%/yr | −3%/yr | 1.41.1× | 0% | 530 in 2030+0.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 31 | 2,414−5.1%/yr | −5.1%/yr | 6.01.2× | 73% | 2,260 in 2030−1.1%/yr |
| Ear tubes & middle ear surgery | 3 | 248−7.3%/yr | −7.3%/yr | 0.61.9× | 19% | 210 in 2030−3.1%/yr |
| Sleep apnea & airway implants | 5 | 148+58%/yr | +58%/yr | 0.31.5× | 0% | 150 in 2030−0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 36 | 2,413−3.9%/yr | −3.9%/yr | 6.30.9× | 14% | 2,390 in 2030−0.2%/yr |
| Tumor & fibroid embolization | 3 | 167−2.6%/yr | −2.6%/yr | 0.40.7× | 37% | 260 in 2030+7.6%/yr |
| Tumor ablation | 0 | 112+4%/yr | +4%/yr | 0.30.9× | 0% | 290 in 2030+17%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 83 | 11,500+25%/yr | +25%/yr | 27.61.0× | 78% | 18,600 in 2030+8.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 38 | 2,141−6.6%/yr | −6.6%/yr | 5.51.0× | 9% | 1,980 in 2030−1.3%/yr |
| LAA occlusion & loop recorders | 39 | 1,487+8.4%/yr | +8.4%/yr | 3.10.9× | 11% | 2,580 in 2030+9.6%/yr |
| EP ablation | 27 | 1,317+5.2%/yr | +5.2%/yr | 2.70.7× | 0% | 2,790 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 80 | 3,628−10%/yr | −10%/yr | 7.11.2× | 5% | 3,290 in 2030−1.6%/yr |
| Structural heart (TAVR, TEER) | 50 | 724+2.7%/yr | +2.7%/yr | 1.50.9× | 0% | 940 in 2030+4.5%/yr |
| Mechanical circulatory support | 0 | 290−8.2%/yr | −8.2%/yr | 0.71.3× | 0% | 300 in 2030+0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 10 | 196+0.2%/yr | +0.2%/yr | 0.51.2× | 0% | 250 in 2030+4.2%/yr |
| Aneurysm & intracranial embolization | 7 | 162+8.9%/yr | +8.9%/yr | 0.40.9× | 0% | 220 in 2030+5%/yr |
| DBS & VNS | 2 | 151−6.2%/yr | −6.2%/yr | 0.41.1× | 0% | 1,100 in 2030+39%/yr |
| CSF shunts | 1 | 126−3%/yr | −3%/yr | 0.31.7× | 0% | 260 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 120 | 22,385−5.1%/yr | −5.1%/yr | 53.70.9× | 61% | 20,400 in 2030−1.5%/yr |
| Vitreoretinal surgery | 14 | 1,034−4.5%/yr | −4.5%/yr | 2.61.0× | 72% | 980 in 2030−1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 259 | 49,097−5.9%/yr | −5.9%/yr | 125.41.1× | 50% | 47,000 in 2030−0.7%/yr |
| ERCP & endoscopic ultrasound | 24 | 1,549−3.9%/yr | −3.9%/yr | 3.91.2× | 11% | 1,580 in 2030+0.3%/yr |
| Bronchoscopy & lung nodule | 18 | 1,193+5.7%/yr | +5.7%/yr | 3.00.9× | 0% | 2,510 in 2030+13%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.